Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy. | Exp Mol Med | 2023 | 37696895 | PubTator, text mining | PubMed |
| The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma. | Cancers (Basel) | 2023 | 37686584 | PubTator, text mining | PubMed |
| A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance. | J Ovarian Res | 2023 | 37674251 | PubTator, text mining | PubMed |
| Complete human day 14 post-implantation embryo models from naive ES cells. | Nature | 2023 | 37673118 | PubTator, text mining | PubMed |
| Expression analysis of inhibitory B7 family members in Alzheimer's disease. | Metab Brain Dis | 2023 | 37665469 | PubTator, text mining | PubMed |
| Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications. | Front Immunol | 2023 | 37662949 | PubTator, text mining | PubMed |
| Unraveling dynamic interactions between tumor-associated macrophages and consensus molecular subtypes in colorectal cancer: An integrative analysis of single-cell and bulk RNA transcriptome. | Heliyon | 2023 | 37662758 | PubTator, text mining | PubMed |
| A fatty acid-rich fraction of an endolichenic fungus Phoma sp. suppresses immune checkpoint markers via AhR/ARNT and ESR1. | Heliyon | 2023 | 37662726 | PubTator, text mining | PubMed |
| Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands. | Ther Adv Vaccines Immunother | 2023 | 37662491 | PubTator, text mining | PubMed |
| Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors. | J Transl Med | 2023 | 37658364 | PubTator, text mining | PubMed |
| Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients. | Medicine (Baltimore) | 2023 | 37653738 | PubTator, text mining | PubMed |
| Research progress and hotspots on macrophages in osteoarthritis: A bibliometric analysis from 2009 to 2022. | Medicine (Baltimore) | 2023 | 37653729 | PubTator, text mining | PubMed |
| Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework. | Eur J Med Res | 2023 | 37649103 | PubTator, text mining | PubMed |
| Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness? | Adv Pharm Bull | 2023 | 37646055 | PubTator, text mining | PubMed |
| Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research. | Front Immunol | 2023 | 37646041 | PubTator, text mining | PubMed |
| Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance. | Discov Oncol | 2023 | 37642765 | PubTator, text mining | PubMed |
| Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma. | BMC Cancer | 2023 | 37641032 | PubTator, text mining | PubMed |
| Exploring the regulatory role of lncRNA in cancer immunity. | Front Oncol | 2023 | 37637063 | PubTator, text mining | PubMed |
| Generation of Human Endometrial Assembloids with a Luminal Epithelium using Air-Liquid Interface Culture Methods. | Adv Sci (Weinh) | 2023 | 37635169 | PubTator, text mining | PubMed |
| An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma. | Med Sci Monit | 2023 | 37632137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=16